SYST-03 INCIDENCE AND SURVIVAL OF PATIENTS WITH INTRACRANIAL METASTATIC DISEASE AND ERBB2-POSITIVE GASTROINTESTINAL CANCERS: A RETROSPECTIVE COHORT STUDY

BACKGROUND: Intracranial metastatic disease (IMD) is a mortality-driving complication of gastrointestinal (GI) cancers. In breast cancer, ERBB2 positivity is associated with shorter overall survival (OS) and increased risk of IMD, and while ERBB2 status is relevant in primary GI cancer, no study has...

Descripción completa

Detalles Bibliográficos
Autores principales: Sherman, Madison, Erickson, Anders W, Das, Sunit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354209/
http://dx.doi.org/10.1093/noajnl/vdac078.082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354209/
http://dx.doi.org/10.1093/noajnl/vdac078.082

Ejemplares similares